| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Nicole M Verrills | Q54877950 |
| P2093 | author name string | Nicole M Verrills | |
| P2860 | cites work | Current two-dimensional electrophoresis technology for proteomics | Q22252855 |
| Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis | Q24311617 | ||
| Functional proteomic analysis of human nucleolus | Q24318249 | ||
| Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer | Q24329242 | ||
| Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness | Q24533487 | ||
| Shotgun identification of protein modifications from protein complexes and lens tissue | Q24534333 | ||
| High resolution two-dimensional electrophoresis of proteins | Q24608190 | ||
| A data review and re-assessment of ovarian cancer serum proteomic profiling | Q24806513 | ||
| Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. | Q27824766 | ||
| Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 | ||
| Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 | ||
| A gene-expression signature as a predictor of survival in breast cancer | Q27860945 | ||
| Molecular portraits of human breast tumours | Q28032461 | ||
| Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics | Q28131742 | ||
| Large-scale analysis of the yeast proteome by multidimensional protein identification technology | Q28131778 | ||
| Correlation between protein and mRNA abundance in yeast | Q28137554 | ||
| Quantitative analysis of complex protein mixtures using isotope-coded affinity tags | Q28145324 | ||
| Mass spectrometry-based proteomics | Q28182890 | ||
| Interaction of kinesin motor domains with alpha- and beta-tubulin subunits at a tau-independent binding site. Regulation by polyglutamylation | Q71246680 | ||
| Protein microarrays: prospects and problems | Q73621090 | ||
| Counterpoint: The vision for a new diagnostic paradigm | Q73708955 | ||
| Influence of index of individuality on false positives in repeated sampling from healthy individuals | Q73849027 | ||
| Cancer Tumor antigens | Q74076460 | ||
| CDNA microarray analysis of chronic myeloid leukemia | Q74217769 | ||
| A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis | Q74405612 | ||
| Fluorescent dual colour 2D-protein gel electrophoresis for rapid detection of differences in protein pattern with standard image analysis software | Q74527395 | ||
| Direct analysis of laser capture microdissected cells by MALDI mass spectrometry | Q78547548 | ||
| Proteomic approaches to tumor marker discovery | Q78586166 | ||
| A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard | Q78842195 | ||
| Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status | Q80809839 | ||
| Proteomic analysis of global alteration of protein expression in squamous cell carcinoma of the esophagus | Q81128151 | ||
| Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects | Q81223783 | ||
| Albumin depletion of human plasma also removes low abundance proteins including the cytokines | Q81466173 | ||
| Protein analysis on a proteomic scale | Q35084572 | ||
| Disease proteomics | Q35084579 | ||
| Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer | Q35177848 | ||
| Drug resistance mechanisms in cancer cells: a proteomics perspective. | Q35180685 | ||
| Lineage-related polypeptide markers in acute lymphoblastic leukemia detected by two-dimensional gel electrophoresis | Q35589245 | ||
| Bioinformatics strategies for proteomic profiling | Q35826759 | ||
| Multiplexed sandwich assays in microarray format | Q35840017 | ||
| Circulating nucleic acids in plasma and serum: past, present and future | Q35841306 | ||
| Imatinib mesylate--gold standards and silver linings | Q35983460 | ||
| Candidate-based proteomics in the search for biomarkers of cardiovascular disease | Q35990040 | ||
| Mass spectrometry-based expression profiling of clinical prostate cancer | Q36032608 | ||
| Properties of 13C-Substituted Arginine in Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) | Q28201288 | ||
| Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells | Q28203404 | ||
| Coordination of posttranslational modifications of bovine brain alpha-tubulin. Polyglycylation of delta2 tubulin | Q28204702 | ||
| Nuclear membrane proteins with potential disease links found by subtractive proteomics | Q28205222 | ||
| Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function | Q28218547 | ||
| Difference gel electrophoresis: a single gel method for detecting changes in protein extracts | Q28258266 | ||
| Polyglutamylation of Tubulin as a Progressive Regulator of in Vitro Interactions between the Microtubule-Associated Protein Tau and Tubulin | Q28286761 | ||
| Changes in the mitochondrial proteome from mouse hearts deficient in creatine kinase | Q28589463 | ||
| The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis | Q29616121 | ||
| Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer | Q29617440 | ||
| A proteomic view of the Plasmodium falciparum life cycle | Q29618807 | ||
| Continuous free-flow electrophoresis separation of cytosolic proteins from the human colon carcinoma cell line LIM 1215: a non two-dimensional gel electrophoresis-based proteome analysis strategy. | Q30328546 | ||
| From genomics to proteomics | Q30482453 | ||
| Correlation of clinical data with proteomics profiles in 24 patients with B-cell chronic lymphocytic leukemia | Q30624003 | ||
| Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues | Q30662372 | ||
| Identification by mass spectrometry of a new alpha-tubulin isotype expressed in human breast and lung carcinoma cell lines | Q30666703 | ||
| Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer | Q30698088 | ||
| Proteomics in early detection of cancer | Q30724487 | ||
| Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments | Q30749426 | ||
| Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry | Q30757635 | ||
| Possible prediction of chemoradiosensitivity of esophageal cancer by serum protein profiling. | Q30802729 | ||
| Use of proteomic patterns in serum to identify ovarian cancer | Q30819686 | ||
| Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry | Q30864196 | ||
| Detection of cancer-specific markers amid massive mass spectral data | Q30885514 | ||
| Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two-dimensional electrophoresis | Q30927294 | ||
| Multiplex proteomic analysis by two-dimensional differential in-gel electrophoresis. | Q30966273 | ||
| Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction | Q30978394 | ||
| High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast. | Q31027104 | ||
| High-resolution serum proteomic features for ovarian cancer detection | Q31066608 | ||
| Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system | Q31092474 | ||
| 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers | Q31092484 | ||
| Chemical approaches for functionally probing the proteome | Q31092499 | ||
| Proteomics in pathology research. | Q31105602 | ||
| Antigens secreted from Mycobacterium tuberculosis: identification by proteomics approach and test for diagnostic marker | Q31113792 | ||
| Stable isotope methods for high-precision proteomics. | Q36062702 | ||
| Real world TB vaccines: clinical trials in TB-endemic regions | Q36065383 | ||
| The clinical application of proteomics | Q36129146 | ||
| Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. | Q36134724 | ||
| Imatinib resistance in gastrointestinal stromal tumors. | Q36157319 | ||
| Diagnostic developments involving cell-free (circulating) nucleic acids | Q36242440 | ||
| Proteomics in rheumatology: a new direction for old diseases. | Q36272333 | ||
| Deciphering protein molecular signatures in cancer tissues to aid in diagnosis, prognosis, and therapy | Q36328570 | ||
| A survey of the humoral immune response of cancer patients to a panel of human tumor antigens | Q36400634 | ||
| Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 ("Iressa"). | Q36643855 | ||
| Identification of two related markers for common acute lymphoblastic leukemia as heat shock proteins | Q40346246 | ||
| Proteomic signature of human cancer cells | Q40518297 | ||
| Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease | Q40630247 | ||
| Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-sigma (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas | Q40919523 | ||
| An information-intensive approach to the molecular pharmacology of cancer. | Q41134023 | ||
| New paths in human cancer serology | Q41821668 | ||
| Proteomic strategies to reveal tumor heterogeneity among urothelial papillomas | Q42523148 | ||
| Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells | Q43691869 | ||
| Microtubule alterations and mutations induced by desoxyepothilone B: implications for drug-target interactions | Q43907613 | ||
| Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer | Q43937165 | ||
| Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells | Q44409466 | ||
| The use of proteomics in the discovery of serum biomarkers from patients with severe acute respiratory syndrome. | Q44615750 | ||
| Serum proteomic profiles suggest celecoxib-modulated targets and response predictors | Q44846657 | ||
| Proteome and transcriptome analysis of retinoic acid-induced differentiation of human acute promyelocytic leukemia cells, NB4. | Q44978181 | ||
| Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment | Q45007602 | ||
| Allergen-induced proteolytic cleavage of annexin-1 and activation of cytosolic phospholipase A2 in the lungs of a mouse model of asthma | Q45066489 | ||
| Autoantigen microarrays for multiplex characterization of autoantibody responses | Q46316594 | ||
| Immunoaffinity separation of plasma proteins by IgY microbeads: meeting the needs of proteomic sample preparation and analysis | Q46616857 | ||
| Gene expression profiling of pediatric acute myelogenous leukemia | Q47266175 | ||
| Serial analysis of plasma proteomic signatures in pediatric patients with severe acute respiratory syndrome and correlation with viral load | Q47391790 | ||
| Human and mouse proteomic databases: novel resources in the protein universe. | Q47789207 | ||
| Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry | Q47915916 | ||
| A method for the comprehensive proteomic analysis of membrane proteins | Q48337081 | ||
| Protein expression profiling identifies subclasses of breast cancer and predicts prognosis. | Q48712020 | ||
| Classification of pediatric acute lymphoblastic leukemia by gene expression profiling | Q52017263 | ||
| Complementing genomics with proteomics: the membrane subproteome of Pseudomonas aeruginosa PAO1. | Q52066552 | ||
| A protein expression database for the molecular pharmacology of cancer. | Q52195892 | ||
| Identification of a cellular polypeptide that distinguishes between acute lymphoblastic leukemia in infants and in older children. | Q53516829 | ||
| Increased phosphorylation of nuclear phosphoproteins in human lung‐cancer cells resistant to cis‐diamminedichloroplatinum(II) | Q54277017 | ||
| Isoelectric focusing in immobilized pH gradients: Principle, methodology and some applications | Q56032045 | ||
| Comparative proteomics of primitive hematopoietic cell populations reveals differences in expression of proteins regulating motility | Q57011012 | ||
| Combined genetic and transcriptional profiling of acute myeloid leukemia with normal and complex karyotypes | Q58861922 | ||
| Running before we can walk? | Q59093391 | ||
| Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling | Q61910882 | ||
| Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer | Q63446333 | ||
| Profiling proteins related to amyloid deposited brain of Tg2576 mice | Q31113804 | ||
| Proteome analysis of differential protein expression in allergen-induced asthmatic mice lung after dexamethasone treatment | Q31113832 | ||
| Quantitative profiling of plasma peptides in asthmatic mice using liquid chromatography and mass spectrometry | Q31113859 | ||
| Potential interferences from blood collection tubes in mass spectrometric analyses of serum polypeptides | Q31131974 | ||
| Differential protein analysis of spasomolytic polypeptide expressing metaplasia using laser capture microdissection and two-dimensional difference gel electrophoresis. | Q31144025 | ||
| Proteome analysis of vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel cytoskeletal alterations. | Q31155409 | ||
| Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. | Q31952745 | ||
| Proteomic comparison of membrane and extracellular proteins from invasive (PAO1) and cytotoxic (6206) strains of Pseudomonas aeruginosa | Q33184774 | ||
| Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays | Q33194505 | ||
| Protein chip array profiling analysis in patients with severe acute respiratory syndrome identified serum amyloid a protein as a biomarker potentially useful in monitoring the extent of pneumonia | Q33206775 | ||
| Towards a proteomic analysis of atopic dermatitis: a two-dimensional-polyacrylamide gel electrophoresis/mass spectrometric analysis of cultured patient-derived fibroblasts | Q33207680 | ||
| Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome | Q33209073 | ||
| Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study. | Q33209768 | ||
| Analytical assessment of MALDI-TOF Imaging Mass Spectrometry on thin histological samples. An insight in proteome investigation | Q33215737 | ||
| Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry | Q33222772 | ||
| Differential exoprotease activities confer tumor-specific serum peptidome patterns | Q33230965 | ||
| Serum proteomic fingerprints of adult patients with severe acute respiratory syndrome. | Q33232100 | ||
| Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia--an in vivo study. | Q33233029 | ||
| p53 Antibodies in the sera of patients with various types of cancer: a review | Q33892337 | ||
| Subproteomics based upon protein cellular location and relative solubilities in conjunction with composite two-dimensional electrophoresis gels | Q33901664 | ||
| Cancer proteomics: from identification of novel markers to creation of artifical learning models for tumor classification | Q33901683 | ||
| An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer | Q33933918 | ||
| Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist | Q34019954 | ||
| Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology | Q34099409 | ||
| 2D or not 2D. Two-dimensional gel electrophoresis | Q34134750 | ||
| Protein arrays and microarrays | Q34134761 | ||
| Protein microarrays: meeting analytical challenges for clinical applications. | Q34194188 | ||
| Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. | Q34388251 | ||
| Proteomics for studying cancer cells and the development of chemoresistance | Q34447866 | ||
| Mass spectrometry and the age of the proteome | Q34454564 | ||
| Current achievements using ProteinChip Array technology | Q34517742 | ||
| Bacterial proteomics and vaccine development | Q34706748 | ||
| Proteomics in translational cancer research: toward an integrated approach | Q35057057 | ||
| Recent developments in protein microarray technology | Q35060489 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 99-116 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | Clinical Biochemist Reviews | Q15766391 |
| P1476 | title | Clinical proteomics: present and future prospects | |
| P478 | volume | 27 |
| Q37408334 | 18O labeling over a coffee break: a rapid strategy for quantitative proteomics |
| Q82125146 | Bar-coded hydrogel microparticles for protein detection: synthesis, assay and scanning |
| Q92134637 | Current Biochemical Applications and Future Prospects of Chlorotoxin in Cancer Diagnostics and Therapeutics |
| Q90138172 | Diverse conditions support near-zero growth in yeast: Implications for the study of cell lifespan |
| Q35835560 | Does transthyretin function as one of contributors for preeclampsia? |
| Q55266735 | Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants. |
| Q37780790 | Genomics and pharmacogenomics of dementia |
| Q37780792 | Genomics and pharmacogenomics of schizophrenia |
| Q30492953 | High-throughput flow alignment of barcoded hydrogel microparticles |
| Q28540157 | Identification of reduced circulating haptoglobin concentration as a biomarker of the severity of pulmonary embolism: a nontargeted proteomic study |
| Q90519520 | Matrices (re)loaded: Durability, viability, and fermentative capacity of yeast encapsulated in beads of different composition during long-term fed-batch culture |
| Q34113055 | OMICS: Current and future perspectives in reproductive medicine and technology |
| Q46106384 | Open innovation networks between academia and industry: an imperative for breakthrough therapies |
| Q37031522 | Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease |
| Q37111344 | Pharmacogenomics and therapeutic prospects in dementia |
| Q33289397 | Self-assembled monolayers for MALDI-TOF mass spectrometry for immunoassays of human protein antigens |
Search more.